Role of screening in urological malignancies

    loading  Checking for direct PDF access through Ovid

Abstract

Urological malignancies, in particular prostate and bladder cancers, are significant causes of morbidity and mortality. Alasdair Scott discusses whether these conditions are suitable for population-based screening programmes, which must balance mortality reductions with the harm done by investigation, overdiagnosis and overtreatment.

Related Topics

    loading  Loading Related Articles